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ABSTRACT Advance care planning (ACP) is a communication process for mapping a patient’s wishes
and priorities for end-of-life care. In preparation for the introduction of ACP in Norway, we wanted to
explore the views of Norwegian pulmonary patients on ACP.
We conducted four focus group interviews in a Norwegian teaching hospital, with a sample of 13
patients suffering from chronic obstructive pulmonary disease, lung cancer or lung fibrosis. Analysis was
by systematic text condensation.
Participants’ primary need facing end-of-life communication was “the comforting safety”, implying
support, information and transparency, with four underlying themes: 1) provide good team players;
2) offer conversations with basic information; 3) seize the turning point; and 4) balance transparency.
Good team players were skilled communicators knowledgeable about treatment and the last phase of life.
Patients preferred dialogues at the time of diagnosis and at different “turning points” in the disease
trajectory and being asked carefully about their needs for communication and planning. Transparency was
important, but difficult to balance.
ACP for patients with life-threatening pulmonary disease should rest upon an established
patient–doctor/nurse relationship and awareness of turning points in the patient’s disease progression.
Individually requested and tailored information can support and empower patients and their relatives.
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Introduction
Advance care planning (ACP) is a structured communication process enabling individuals to define goals
and preferences for future medical treatment and care, to discuss these goals and preferences with family
and healthcare providers and to record and review these preferences if appropriate [1]. During one or
more conversations, physical, social, psychological and spiritual aspects of life are discussed [2]. Studies
have shown that using a list of questions as a guide is better than using a paper-based scheme and tick
boxes [2]. Important details can be outlined in a document, often as part of the medical record, and may
be reconsidered and altered if the patient changes his/her mind [2].
ACP is in common use in several English-speaking countries, and effects on improved care and quality of
life for both patients and their relatives have been demonstrated [2, 3]. So far, ACP has not been
introduced in any Norwegian hospital, but Norwegian health authorities have encouraged research on
ACP and pointed to the need for implementation of guidelines and advisory material [4, 5]. In the general
population, the concept of ACP is mostly unknown.
Patients with advanced incurable lung diseases are a diverse group, comprising patients who may have
been living with chronic obstructive pulmonary disease (COPD) for years [6, 7], patients with an insidious
progression of pulmonary fibrosis [8] and patients with lung cancer who may have galloping trajectories
with only months between the time of diagnosis and death [9]. All these patients often have burdensome
symptoms such as dyspnoea and pain, and they often share a feeling of their life being threatened, hence,
planning for the best possible care at the end of life (EoL) is important [10–12]. Believing ACP to be a
feasible tool for Norwegian healthcare professionals and their patients, and working particularly with
patients with advanced lung diseases (authors NEH and MAS), we designed a study to explore pulmonary
patients’ needs and preferences regarding ACP in order to prepare for the introduction of ACP in
Norwegian hospitals.
Material and methods
We conducted a focus group study interviewing patients with advanced pulmonary disease [13, 14].
Participants and study setting
The focus group interviews took place at the outpatient clinic of the Department of Thoracic Medicine at
Haukeland University Hospital in Bergen, Norway. This department has ∼17000 outpatient consultations
and ∼3000 in-patient admissions per year. All participants were recruited from this department.
The recruitment period lasted from January 2014 to February 2015. Patients receiving treatment for
advanced lung cancer, COPD or lung fibrosis were invited to participate by a dedicated research nurse,
other nurses on the ward or at the outpatient clinic, or attending physicians. 42 patients were asked to
participate. 17 (40%) agreed, but only 13 participated, due to the worsening condition of the others. As
soon as a group was established through successive recruitment, an interview took place. We strived for a
purposive sample, aiming for diversity in age, sex, diagnosis and education. Our final sample consisted of
six males and seven females, distributed between four focus groups. 12 patients were Norwegian and one
was Danish. Inclusion and exclusion criteria are listed in table 1.
Ethical statement
The study was approved by the regional committee for medical and health research ethics of Western
Norway (REK number 2013/1479). Written informed consent was obtained from all participants. To
TABLE 1 Inclusion and exclusion criteria for focus group participants
Inclusion
criteria
Aged >18 years
In- or outpatient at the department of thoracic medicine (Haukeland University Hospital,
Bergen, Norway)
Diagnosed with advanced (noncurable) pulmonary disease, e.g. inoperable lung cancer,
COPD or pulmonary fibrosis
Able to communicate orally in Norwegian
Able and willing to provide written informed consent
Exclusion
criteria
Cognitive impairment
Other circumstances (e.g. anxiety, impaired hearing or reduced functional ability)
representing a severe challenge to group participation and dynamics
COPD: chronic obstructive pulmonary disease.
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secure confidentiality, pseudonym participant names were used in the transcription and analysis, and
patients were asked specifically not to share information about other co-informants elsewhere. Audio files
from the interviews were stored safely on a research server belonging to the University of Bergen.
Data collection
NEH served as facilitator in all interviews and MAS acted as secretary taking field notes. No relatives
attended the groups. The facilitator invited participants to talk about EoL issues and communication
preferences regarding these. To balance eager participants against the more modest, we guided the
discussions using questions, both to the whole group and directly to some of the participants. The
interviews lasted 49–66 min and were transcribed verbatim by a secretary. Data collection was closed after
four focus group interviews, as we assessed the data as sufficient to illuminate the research topic according
to the concept of information power [15].
In addition to the data collected in the focus group interviews, demographic and medical information was
taken from the medical record and registered in a non-identifiable form to characterise the study
population.
Analysis
Data analysis was performed in collaboration between the authors NEH and MAS, using systematic text
condensation, a cross-case thematic analysis suitable for both focus group data and individual
semi-structured interviews [16]. The analysis proceeded through the following stages: 1) reading all the
material to obtain an overall impression, bracketing previous preconceptions; 2) identifying units of
meaning, representing different aspects of the patients’ views on and experiences of ACP; 3) condensing
and abstracting the meaning within each of the coded groups; and 4) summarising the contents of each
code group to generalised descriptions and concepts reflecting the most important needs and perspectives
regarding ACP as reported by the informants. Analysis was done stepwise with new interviews
supplementing the sample, and a decision trail documented the choices during the analytical process [17].
Results
Having an advanced life-threatening pulmonary disease gave the patients a need for security concerning
treatment and human relationships, in hospital as well as well as in private life. The participants’ primary
need facing EoL communication was “the comforting safety”, implying support, information and
transparency, with four underlying themes: 1) provide good team players; 2) offer conversations with basic
information; 3) seize the turning point; and 4) balance transparency. Good team players were skilled
communicators knowledgeable about treatment and the last phase of life. Patients preferred dialogues at
the time of diagnosis and at different “turning points” in the disease trajectory, and being asked carefully
about their needs for communication and planning. Transparency was important, but difficult to balance.
Demographic and disease-related information for the focus group participants is presented in table 2 and
figure 1. All citations from participants are presented with pseudonyms.
Provide good team players
“The comforting safety” could be established by providing the patient with good team players. The
participants talked about the importance of having a network of people who were knowledgeable,
supportive and caring. These team players were found both in their own family, among friends and among
healthcare professionals. At the hospital, the participants wanted to be offered ACP conversations, as
expressed by a woman in her fifties:
I wish there was an option when you received the message that you have limited time left to live; that a doctor
could talk with me about the situation and what worries me. (…) It is difficult to talk about this, but I think it
can help me to talk with someone knowledgeable. (Suzanna, lung cancer)
Additionally, knowing they had good relationships with professionals in the hospital and a reliable way to
get in contact with them, now and in the future, was important. Everybody in the focus groups would
prefer the Department of Thoracic Medicine to offer conversations about the last phase of life. However,
they pointed to the need for delicacy and respect when extending an invitation to such conversations,
giving the invited patient the possibility of accepting or rejecting participation. They would prefer to have
EoL conversations with people they already knew in the department, regardless of profession; it could be a
nurse, a doctor or a psychologist. According to the participants, a professional having knowledge about
both the patient and his/her disease was considered to be the right person in the healthcare system to talk
to, including when it came to conversations about the last phase of life. Some argued the age difference
should not be too big between patient and healthcare professional; indicating that they preferred a person
either about their own age or older. The quality of the relationship and rapport were the most important
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aspects when choosing a team player; the sex of the individual followed. The most important qualification
when offering EoL conversations was being competent in supportive teamwork and clinical
communication, making the patient feel safe and understood while at the same time imparting important
information:
I don’t think it is painful to talk about dying as long as I have a person teaming up with me, and who really
knows what it is all about. (Nancy, lung cancer)
Most participants emphasised that it might be painful and difficult to talk about EoL issues. Several
mentioned they were not capable of talking about everything on their mind with their nearest and dearest,
or abstained from doing so in order not to hurt them. Several stories referred in particular to situations at
times of disease worsening, when patients wanted a conversation with relatives, facilitated by healthcare
professionals:
TABLE 2 Demographic and disease-related information for focus group participants
Age years 65 (52–80)
Sex
Female 7
Male 6
Occupation
Shop assistant/office worker/factory worker 9
Academic 1
Seaman 2
Self-employed 1
Living situation
Alone 3
With spouse/partner 10
Disease
Small cell lung cancer disseminated disease 2
Nonsmall cell lung cancer stage III–IV 5
COPD GOLD criteria stage IV 4
Idiopathic pulmonary fibrosis 2
Treatment
Inhalation therapy 5
Chemotherapy 7
Immune-modulating therapy 3
Radiation therapy 1
Comorbidities
Asthma, COPD, emphysema, bronchiectases, OSAS 9
Chronic pain, osteoporosis and/or arthrosis 7
Coronary heart disease 6
Diabetes mellitus 2
Dermatological diseases 3
Other malignancies 2
Renal failure 2
Medication
Nonopioid analgesics 6
Opioid analgesics 7
Corticosteroids 6
Benzodiazepines 3
Antiemetics 3
Laxatives 4
Antidiabetics 2
Inhalation aerosol 5
Antihypertensives, statins, diuretics or nitrates 4
WHO performance status
I 9
II 3
III 1
Data are presented as mean (range) or n. COPD: chronic obstructive pulmonary disease; GOLD: Global
Initiative for Chronic Obstructive Lung Disease; OSAS: obstructive sleep apnoea syndrome; WHO: World
Health Organization.
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I am rather open minded, we are open minded at home, but I don’t manage to talk about death. I think it may
be easier to talk about death with someone who’s on the outside. (Gary, COPD)
Offer conversations with basic information
Many participants stressed the importance of receiving the information they needed. Information about
present and future symptom management was important for most of the participants. Several mentioned
anxiety-provoking dyspnoea as well as fearing future pain and other distressing symptoms. They wanted
information about topics such as practical aids, medications, legal rights and social benefits, finance and
who to contact when they needed help. Talking about challenges and services available for the last phase
of life was mentioned as a prerequisite for good quality of life:
Because I have limited time left to live, I want to know everything that may happen to me. I want healthcare
professionals in the hospital to inform me of my rights and benefits, the expected disease trajectory and the last
phase of life in order to fulfil my wish for dignity at the end of life. (Nancy, lung cancer)
Others expressed a wish for thorough information in the future, underlining that they did not feel ready
for it yet. Some emphasised how important it was that doctors did not give wrong information, but
ensured adequate knowledge about treatment and side-effects, enabling patients to make decisions in line
with their own preferences. The participants did not talk much about future planning. Yet, when thinking
about a possible future situation when they no longer could make decisions for themselves, some of them
mentioned a wish for a proxy:
My children shall be my attorneys if I should become so ill I am no longer in control over my own thoughts; so
that I will not receive more treatment than I would have wanted. (Paul, lung cancer)
Participants described how information about the disease as well as social benefits supported relatives in a
difficult situation. Some expressed difficulties knowing what to ask for when they had an appointment
with the doctor, but at the same time wished to know what was happening to them. In addition, they
described the immense challenge of being severely ill, including reduced capacity to remember all
eventualities and needs. Thus, they wished for a proactive approach from the healthcare system, with the
option to refuse an offer of conversation rather than having to ask for it themselves when they already
were so heavily burdened, outlined like this:
I have so many thoughts on my mind now that I’m ill, so it is difficult to remember what I should ask about; it
is better that they offer information about what they think I need to know. (Evangeline, lung cancer)
Seize the turning point
Most participants wanted a tailored EoL dialogue at the time of diagnosis. However, the COPD patients
suggested that their entering the most serious disease stage (stage IV) would be a suitable time for an ACP
conversation, even if they might have several years left to live. All participants underlined that an
individual approach was mandatory, respecting each patient’s particular needs:
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FIGURE 1 Symptom scores for the study participants using the Edmonton Symptom Assessment System,
revised (ESAS-r), a numerical rating scale. 0: no symptom; 10: worst possible symptom. Data are presented
as mean (range).
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I think there is a need for more than one conversation, and that we could be offered one in the beginning, then
one or two later on when the condition is getting worse. It must be an individual approach. (Peter, pulmonary
fibrosis)
It was also important that they received a “warning shot” in advance, to be able to prepare for the
conversation mentally and practically, and especially to invite persons they wanted to be present. They
regarded it as important that ACP conversations were held while the patient was cognitively sound, and
that distressing symptoms such as dyspnoea and pain were well treated beforehand. Some participants
wished for an early informative and prognostic dialogue, before they became so ill that it was difficult to
make a prospective care plan. One patient described how she had been struggling alone without help from
healthcare professionals after having received her diagnosis, searching to find resilience and unable to talk
with her close ones. After some years, she had finally found a sort of balance:
I wanted a conversation about diagnosis and prognosis much earlier in the trajectory than what I have been
offered. Now, after four years, it is too late. (Evangeline, lung cancer)
Even when patients themselves received adequate and successive disease-related information, this was not
necessarily enough to establish a common ground and understanding of EoL issues in their families.
Several participants expressed the need for more help informing their closest ones about their diagnosis
and prognosis. The participants named key turning points that often were consistent with major medical
changes. Examples of such turning points were an infection triggering change, a new metastasis, increasing
pain, increasing dyspnoea, loss of a function, decline in their general condition and stopping
chemotherapy. At the time of treatment changes, several had wished for thorough information in order to
reduce anxiety:
It is something about change; that every change can increase anxiety. (Nathan, COPD)
Balance transparency
Some participants wanted open and honest conversations about their disease, yet acknowledging it could
be difficult to find a proper balance. It was upsetting if friends, neighbours and other acquaintances
avoided meeting them because they felt it was difficult to talk with them. Transparency through honest
conversations about their state of health and feelings was regarded very important:
Being open about everything concerning me and my family makes me feel secure. I feel safe and I feel that I
make those around me safe, too, by being open. (Nancy, lung cancer)
Some needed transparency about their prognosis to be able to spend their remaining time with their
family in the best way. Receiving news about limited time left to live could yield possibilities for preparing
themselves as well as family members practically and psychologically for the inevitable course of the
disease. Many wanted full openness and information about their disease in order to correctly inform
children and grandchildren, even though this could be difficult to do by themselves:
In the nights, I cried in bed alone without telling everything to my family, but now I no longer try to hide it.
(Evangeline, lung cancer)
There was broad agreement that healthcare professionals should ask the individual patients in a careful
and respecting manner about their need for information and for ACP, as this could be very different from
one patient to another. Documenting all given information in the patient’s medical record, including
any restrictions on what the patient wished to know, was regarded mandatory to avoid information
errors:
The information I’ve received must be documented in my medical record, as well as what I don’t want to know
about my disease. I would find it horrible if I was given more information than I wanted. So I think medical
records should clearly state the patient’s preferred details and content of information. (Miranda, lung cancer)
Discussion
Facing incurable pulmonary disease, our informants described the need for a safe foundation and
comforting understanding provided by EoL discussions with knowledgeable healthcare professionals at
important turning points during the disease trajectory. Here, we discuss the impact of our findings and the
strengths and limitations of this study.
Discussion of the results
Our results are in line with previous research demonstrating that most patients offered ACP conversations
want them [9, 18]. The challenges in finding the desired balance in transparency, both for healthcare
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professionals and patients, has been mentioned by SIOUTA et al. [19]. The concept of the “comforting
safety” created by tailored ACP conversations and how it may improve quality of life among Norwegian
patients with advanced pulmonary disease have not been demonstrated before.
This study expands our knowledge about ACP for pulmonary patients by showing that good relationships
between patients and their healthcare providers are important for the basic trust needed to address
sensitive themes in an ACP conversation. Patients need a tailored approach, both when it comes to the
invitation to ACP conversations as well as the choice of themes. As the participants pointed out, turning
points of the disease trajectory: at the time of diagnosis, a serious infection, progression of the disease, loss
of a function or change in therapy, can bring uncertainty and anxiety. Awareness of these turning points is
important in order to comprehend patients’ special needs and vulnerability, and to seize the opportunity
to introduce ACP conversations. This finding coincides with the recommendations in the Norwegian
Action Programme for Palliative Care [5].
Cultural differences are important factors to consider when starting an ACP programme [20]. Since ACP
has never been used in a Norwegian hospital before, the Norwegian context needed to be explored. This
study demonstrates important attitudes and viewpoints on ACP conversations in Norway before any ACP
programme has been started.
Whether or when it is appropriate to communicate about the last phase of life is not always obvious.
LOVELL and YATES [21] found that factors influencing ACP are complex and multifaceted. Both patients’
and doctors’ attitudes towards the diagnosis and their understanding of the prognosis determine whether
to start an ACP conversation or not. SIOUTA et al. [19] found that patients with chronic heart failure and
COPD are quite unlikely to participate in discussions concerning EoL issues, partly because it is more
complicated to initiate such conversations for patients with a less certain prognosis [22–24]. VERMYLEN
et al. [25] found that doctors avoid conversations about ACP with patients suffering from COPD due to
unique communication barriers, e.g. lack of prognostic factors and difficulty of predicting which patients
are at the highest risk of premature death. Although patients may not initially be interested in discussing
advance directives with their doctors, many patients still have unexpressed wishes that may not be
respected if the conversation is not broached delicately. In addition, the public understanding of these
diseases is not directly linked to dying, so including EoL issues in conversations can elicit negative
reactions from patients [26, 27]. Our patients pointed to the need to give the invitation to ACP
conversations in a gentle manner. They expressed the need for a tailored approach, both concerning the
invitation to discuss ACP, and the choice of themes.
As JABBARIAN et al. [28] have pointed out in a recent review, ACP is surprisingly uncommon in chronic
respiratory disease. SIOUTA et al. [19] have remarked on the implications of not having ACP conversations:
the scarcity of patient–doctor discussions concerning treatment options and preferences, and the frequent
total absence of discussions on EoL issues result in less informed patients. Many patients search for relevant
information on the web, which may make them challenge or question medical decision making [29]. With
the increasing claim for patient autonomy and shared decision-making, ACP can be a tool to facilitate
conversations that may cover this claim.
Some recent trials of clinical EoL communication have taken place in Norway, with promising results [18].
Even so, there is a need for better mapping of similarities and differences among the various groups of
patients with advanced disease in Norway, and we will still have to look to experiences from other
countries where ACP is incorporated into the general healthcare system [30]. Our informants wanted to be
offered ACP conversations, but found it difficult to know what to ask for. Thus, the question is more
about form and content than about having such conversations or not.
TABLE 3 What is known about advance care planning (ACP)? What does this study add?
What is known? ACP is used in many countries, and most patients offered conversations want to discuss it
Using a list of questions as a guide is better than using a paper-based scheme and tick-boxes only
Patients’ and relatives’ satisfaction with end-of-life care increases with the use of ACP
Transparency is difficult to balance
What does
this study
add?
ACP for Norwegian patients with life-threatening pulmonary disease should rest upon an established patient–doctor/nurse
relationship
ACP is perceived to increase the patient’s feeling of “a comforting safety”, meeting their need for support, information and
transparency
ACP conversations involving both patient and relatives may support the relatives in their role as good team players
Turning points of the disease trajectory are times when patients may be especially in need of ACP conversations
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Strengths and limitations
A strength of our study is that the interviewer had extensive experience in EoL conversations, both as a
pulmonologist and palliative care specialist. This experience guided the follow-up questions and influenced
the analytical process. Additionally, we believe that the interviewer’s clinical experience created an
openness towards contrasts and nuances in the participants’ stories. Some of the participants had been in
contact with the hospital’s palliative care team, but they had not met the interviewer as a palliative care
physician.
Exposing vulnerability in a group, compared to individual interviews, may limit data collection, but might
at the same time expand the process, as one participant’s reflections may contribute to an open
atmosphere giving co-participants the courage to talk. The latter was observed in all groups. Hence, we
believe that, facilitated by group reflection, the participants’ experiences were presented without excessive
concern about making a favourable impression.
The process of recruitment was challenging and had a span of ∼1 year. Many patients refused to
participate, for various reasons. In addition, 23% of possible participants did not manage to come to the
focus groups, mainly because of a worsening of their conditions. Many other patients were never asked to
join the study, as both doctors and nurses found it difficult to raise the topic of the study. Consequently,
we might have been able to recruit patients more open to, and more interested in, talking about sensitive
themes, which is a possible limitation of our study. Even so, the sample recruited was representative of the
clinic, and the participants represented variations in age, sex and diagnosis and family, working and living
conditions; adding external validity to the findings to other hospitals treating patients with incurable lung
disease in the same cultural context. Table 3 summarises current knowledge about ACP.
Conclusion
As far as possible, ACP for patients with life-threatening pulmonary disease should rest upon an
established patient–doctor/nurse relationship and awareness of turning points in the patient’s disease
progression. Healthcare professionals can support and empower patients and their relatives by providing
individually requested and tailored information. ACP may strengthen patients’ resilience during the disease
trajectory.
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